Stem cell culture engineering - process scale up and beyond (Q37896560)

25 August 2017

1 reference

title

Stem cell culture engineering - process scale up and beyond (English)

1 reference

25 August 2017

Shikha Sharma

1

1 reference

25 August 2017

Ravali Raju

series ordinal

2

1 reference

25 August 2017

Siguang Sui

series ordinal

3

1 reference

25 August 2017

Wei-Shou Hu

series ordinal

4

1 reference

25 August 2017

1 July 2011

1 reference

25 August 2017

Biotechnology Journal

1 reference

25 August 2017

6

1 reference

25 August 2017

11

1 reference

25 August 2017

1317-1329

1 reference

Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells

25 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Patient characteristics and cell source determine the number of isolated human cardiac progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

The role of stromal stem cells in tissue regeneration and wound repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Growth factors, matrices, and forces combine and control stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Purified hematopoietic stem cells can differentiate into hepatocytes in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Neurodegenerative disease-specific induced pluripotent stem cell research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Bone marrow as a potential source of hepatic oval cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Mesenchymal stem cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Mesenchymal stem cell therapy for cardiac repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Combination stem cell therapy for the treatment of medically refractory coronary ischemia: a Phase I study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Combination stem cell therapy for the treatment of severe limb ischemia: safety and efficacy analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Hepatotoxicity in drug development: detection, significance and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

The systems biology approach to drug development: application to toxicity assessment of cardiac drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Induced pluripotent stem cells from a spinal muscular atrophy patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Human hepatocytes as a tool for studying toxicity and drug metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Progress toward the clinical application of patient-specific pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Personalizing Stem Cell Research and Therapy: The Arduous Road Ahead or Missed Opportunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Characterization of the expression of MHC proteins in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Characterization of a hollow fiber bioartificial liver device

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Islet encapsulation: strategies to enhance islet cell functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Artificial and bioartificial liver devices: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

A novel 3D mammalian cell perfusion-culture system in microfluidic channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Factors Influencing the Loss of β-Cell Mass in Islet Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

The systematic production of cells for cell therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Methods for culturing mouse and human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Derivation of human embryonic stem cells in defined conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Improved development of human embryonic stem cell-derived embryoid bodies by stirred vessel cultivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Expansion and hepatic differentiation of rat multipotent adult progenitor cells in microcarrier suspension culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Scalable stirred-suspension bioreactor culture of human pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Enabling stem cell therapies through synthetic stem cell-niche engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Niche-mediated control of human embryonic stem cell self-renewal and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Extracellular matrix isolated from foreskin fibroblasts supports long-term xeno-free human embryonic stem cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Identification and characterization of small-molecule ligands that maintain pluripotency of human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

The ground state of embryonic stem cell self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Human embryonic and rat adult stem cells with primitive endoderm-like phenotype can be fated to definitive endoderm, and finally hepatocyte-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

The regulation of self-renewal in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Mesenchymal stem cells as therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Sequential development of hematopoietic and cardiac mesoderm during embryonic stem cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Normal timing of oligodendrocyte development from genetically engineered, lineage-selectable mouse ES cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Enhanced reprogramming and cardiac differentiation of human keratinocytes derived from plucked hair follicles, using a single excisable lentivirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

Stem cells in microfluidics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201000435

21 January 2018

Identifiers

DOI

10.1002/BIOT.201000435

1 reference

25 August 2017

1 reference